Page 115 - சிட்டி குழுமம் உலகளாவிய சந்தைகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Bluescape Opportunities Acquisition Corp : Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 18, 2020
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Churchill Capital Corp V : Announces Pricing of $450 Million Initial Public Offering
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Upstart Announces Pricing of Initial Public Offering – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
(1)
Each of the Consent Fee and the Additional Consent Fee (each as defined herein) for the Consent Solicitation with respect to the Notes is an amount, per U.S.$1,000 aggregate principal amount of Notes for which a Holder thereof has delivered valid and unrevoked Consents to the Proposed Amendments (on or prior to the Expiration Date). No accrued interest will be paid in connection with the Consent Solicitation. Holders who validly deliver (and do not validly revoke) their Consents on or prior to the Expiration Date shall receive (i) the Consent Fee and (ii) solely in connection with the Additional Consent Fee Trigger (as defined herein), the Additional Consent Fee, each as, subject to the terms and conditions set forth herein.
Posted on 554
Blackstone (NYSE: BX) today announced that Blackstone Property Partners Life Sciences (“BPPLS”) will acquire a best‐in‐class, 2.3 million square foot portfolio of lab office buildings from a Brookfield Asset Management real estate fund for $3.45 billion. BPPLS is Blackstone Real Estate’s long-term, perpetual capital, core+ return life sciences strategy that owns BioMed Realty, Blackstone’s life science real estate portfolio company. The transaction is expected to close in the first quarter of 2021 subject to customary closing conditions.
Approximately 90% of the portfolio being acquired is concentrated in Cambridge, Massachusetts. Following the completion of the transaction, Blackstone will become the largest life science office owner in Cambridge, and BioMed Realty, which will have an enterprise value of approximately $20 billion, will have two-thirds of its platform concentrated in the Boston